Rockwell Medical Inc (NASDAQ:RMTI) has a beta value of 1.38 and has seen 1.34 million shares traded in the last trading session. The company, currently valued at $71.75M, closed the last trade at $2.22 per share which meant it gained $0.21 on the day or 10.45% during that session. The RMTI stock price is -131.98% off its 52-week high price of $5.15 and 47.75% above the 52-week low of $1.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.6 million shares traded. The 3-month trading volume is 748.35K shares.
The consensus among analysts is that Rockwell Medical Inc (RMTI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Rockwell Medical Inc (NASDAQ:RMTI) trade information
Sporting 10.45% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RMTI stock price touched $2.22 or saw a rise of 5.13%. Year-to-date, Rockwell Medical Inc shares have moved 17.46%, while the 5-day performance has seen it change 6.73%. Over the past 30 days, the shares of Rockwell Medical Inc (NASDAQ:RMTI) have changed -5.73%. Short interest in the company has seen 0.82 million shares shorted with days to cover at 1.51.
Wall Street analysts have a consensus price target for the stock at $9, which means that the shares’ value could jump 75.33% from current levels. The projected low price target is $9.0 while the price target rests at a high of $9.0. In that case, then, we find that the current price level is -305.41% off the targeted high while a plunge would see the stock gain -305.41% from current levels.
Rockwell Medical Inc (RMTI) estimates and forecasts
Figures show that Rockwell Medical Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 20.00% over the past 6 months, with this year growth rate of 117.65%, compared to 11.70% for the industry. Revenue growth from the last financial year stood is estimated to be 20.17%.
2 analysts offering their estimates for the company have set an average revenue estimate of 23.65M for the current quarter. 2 have an estimated revenue figure of 19.12M for the next ending quarter. Year-ago sales stood 22.09M and 22.68M respectively for this quarter and the next, and analysts expect sales will grow by 7.06% for the current quarter and 20.17% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 44.20% over the past 5 years. Earnings growth for 2024 is a modest 102.78% while over the next 5 years, the company’s earnings are expected to increase by 38.00%.
RMTI Dividends
Rockwell Medical Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Rockwell Medical Inc (NASDAQ:RMTI)’s Major holders
Insiders own 12.33% of the company shares, while shares held by institutions stand at 21.27% with a share float percentage of 24.26%. Investors are also buoyed by the number of investors in a company, with Rockwell Medical Inc having a total of 44.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 3.22 million shares worth more than $5.67 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 10.9852% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.12 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.97 million and represent 3.8131% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 2.51% shares in the company for having 811.89 shares of worth $1.8 million while later fund manager owns 355.64 shares of worth $0.79 million as of Sep 30, 2024 , which makes it owner of about 1.10% of company’s outstanding stock.
